Physician-controlled wire-guided ERCPs mean fewer complications and backlogs
At a time when hospitals continue to be at the forefront in the battle against the coronavirus pandemic, one of your main concern remains how to ease backlogs for non-COVID-19 patients and optimally manage staff resources.
Growing patient backlogs threaten to undermine the return to pre-pandemic services, while nurses and other healthcare professionals may be diverted to support front-line colleagues dealing with COVID-19 cases.
It is therefore important to prioritize treatments that lead to fewer patient complications and can be carried out by physicians without assistance.
Endoscopic retrograde cholangiopancreatography (ERCP) remains a key therapeutic option in the management of patients with pancreatico-biliary diseases.
However, pancreatitis is the most common, yet most dreaded complication of ERCP, which can result in significant morbidity and occasional mortality.1
Boston Scientific’s RX Biliary System™ is designed to facilitate access and control during ERCP, facilitating deep biliary duct cannulation, stone and stricture management.
This may be particularly helpful on patients with difficult anatomy, because the physician can work with increased tactile feel and response.
Guidewires facilitate access to both the bile and the pancreatic ducts, maintain cannulation, and allow for the passage and exchange of instruments used in ERCP while keeping the wire locked in place.
Physician-controlled wire guided cannulation reduces the risk of post-ERCP pancreatitis compared with the standard contrast injection method. By facilitating physician-controlled wire guided cannulation, the RX Biliary System plays a role in helping manage the potential complications of ERCP, while helping reduce the procedural time.2
There is also a statistically significant lower rate of post-ERCP complications in patients who underwent endoscopist-controlled wire-guided cannulation compared with assistant-controlled wire-guided cannulation.3
Fewer complications reduce the need for medical surveillance and lead to shorter hospital stays, helping ease patient backlogs.
Short-wire technology has the key advantage of allowing the endoscopist to manipulate the guidewire without the aid of an assistant. This provides optimal control to increase the chance of successful cannulation, but also enables the procedure in centers without dedicated staff for interventional endoscopic procedures.
During the ongoing COVID-19 pandemic, physicians can be less reliant on coordinating procedures with nurses, which could be critical if the assistant is called to help with urgent cases.
Our RX Biliary System and complementary devices offer a broad portfolio of products for pancreatico-biliary access, stone and stricture management.
Read more articles
Managing patient backlogs with meaningful innovation in EUS
Fewer readmissions, reinterventions and complications and increased conclusive diagnoses support managing the backlog of EUS patients.Read Article
Achieving Diagnostic Efficiency
Find out which technologies could help you reach definitive diagnosis earlier.Learn more
And ready for tomorrow.
While we know our support may need to continually evolve, we're here to meet your clinical needs
and to partner with you for solutions to address your unique challenges.
We're here to help
Request a Sales Rep
Fill out a quick form and one of our sales representatives will be in touch to answer any questions you have.
Stay Updated on our Technologies
Sign up for information on our latest technologies and events.